Neurotrophin-3 , a growth factor produced by the body, may be able to combat age-related neurodegeneration in the gut, which could help relieve constipation
Supplied strictly for laboratory research use only
Research assessing mechanisms and long-term outcomes are also needed, according to le Roux
The primary resolution source will be official information from the FDA
Understanding GLP-1 Treatments and Nausea Challenges GLP-1 treatments are widely recognized for their role in managing conditions such as type 2 diabetes and obesity
Its major evidence-based and investigational research areas include: Reduction of visceral adipose tissue Endogenous GH, IGF-1, and IGFBP-3 activation Reduced waist circumference and trunk fat Modest increases in lean body mass Triglyceride and lipid-related changes Hepatic-fat research Exploratory skeletal-muscle composition findings Changes in body composition without substantial overall weight loss The strongest evidence applies to reducing excess abdominal fat in adults with HIV-associated lipodystrophy